Valion Bio (VBIO) Revenue (2021 - 2025)
Valion Bio (VBIO) reported Revenue of $146,000 for Q3 2025, up 15.9% from $126,000 a year earlier and up 69.8% from the prior quarter.
Powered by 
Analysis
Valion Bio (VBIO) Revenue (2021 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2025, Valion Bio's Revenue came in at $482,000, down 49.6% year-over-year; for FY2024, it came in at $780,000, down 33.7% from FY2023.
- Revenue has a three-year compound annual growth rate of -14.7% (FY2021 to FY2024).
- By year, Revenue came in at $1.18 million in FY2023 (-36.1%), $1.84 million in FY2022 (+46.4%) and $1.26 million in FY2021.
- Five-year quarterly Revenue spans a low of $70,000 in Q1 2025 and a high of $528,000 in Q2 2022.
- Year over year, Revenue gained in 1 of the last eight quarters, with an average decline of 30.4%.
- The high point for year-over-year Revenue in five years was Q2 2022 (growth of 97.0%); the low point was Q1 2025 (a decline of 79.0%).
- Per Business Quant data, the three quarters before Q3 2025 came in at $86,000 (Q2 2025), $70,000 (Q1 2025) and $180,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Valion Bio | 378,559.99 | -19.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 146,000.00 |
| Jun 30, 2025 | 86,000.00 |
| Mar 31, 2025 | 70,000.00 |
| Dec 31, 2024 | 180,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 140,000.00 |
| Mar 31, 2024 | 334,000.00 |
| Dec 31, 2023 | 357,000.00 |
| Sep 30, 2023 | 282,000.00 |
| Jun 30, 2023 | 161,000.00 |
| Mar 31, 2023 | 376,000.00 |
| Dec 31, 2022 | 408,000.00 |
| Sep 30, 2022 | 477,000.00 |
| Jun 30, 2022 | 528,000.00 |
| Mar 31, 2022 | 428,000.00 |
| Dec 31, 2021 | 389,000.00 |
| Sep 30, 2021 | 277,000.00 |
| Jun 30, 2021 | 268,000.00 |
| Mar 31, 2021 | 323,000.00 |
API Access
Valion Bio Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();